BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.55 Cr | ₹-2.44 Cr | ₹2.71 Cr | ₹0.37 Cr | ₹0.09 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BAL PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹0.55 Cr |
| Mar2025 | ₹-2.44 Cr |
| Mar2024 | ₹2.71 Cr |
| Mar2023 | ₹0.37 Cr |
| Mar2022 | ₹0.09 Cr |
How is Net Cash Inflow / Outflow of BAL PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.55 Cr | Positive | |
| Mar2025 | ₹-2.44 Cr | Negative | |
| Mar2024 | ₹2.71 Cr | 624.33 | |
| Mar2023 | ₹0.37 Cr | 320.22 | |
| Mar2022 | ₹0.09 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹132.6 Cr | 1.7% | -10.5% | 1.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 1.7% |
-10.5% |
1.6% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses